EU invites Modi for Summit

Image
Press Trust of India New Delhi
Last Updated : Aug 06 2015 | 5:32 PM IST
Four months after it gave a cold shoulder to a proposed visit by Prime Minister Narendra Modi to Brussels, European Union has invited him for the long-pending India-EU summit just before or after the G-20 summit scheduled to be held in November in Turkey.
The European Union had not responded to India's proposal for a brief visit by Modi to Brussels, the headquarters of the 28-member powerful bloc, during his trip to France, Germany and Canada in April.
Minister of State for External Affairs V K Singh, replying to a question in Rajya Sabha, said the EU has invited Modi for an India-EU summit in November.
Singh said it was proposed, in a joint letter addressed to the Prime Minister by the Presidents of the European Council and European Commission, to hold the next summit in Brussels just before or after the next G-20 Summit on November 15-16 in Antalya in Turkey.
Modi is expected to attend the G-20 meet.
"The Summit will provide an opportunity for taking stock of the ongoing cooperation between India and EU and explore ways of further energising bilateral collaboration in areas of mutual interest, including exchange of views on global issues of mutual interest and concern," the Minister said.
The last India-EU Summit had taken place in 2012.
An EU delegation in March had said here that the reason for the EU not responding to Indian proposal was that it was upset with the slow progress of the trial of two Italian marines accused of killing two Indian fisherman in 2012.
The EU has been India's largest trading partner and the two-way commerce stood at USD 101.5 billion in 2013-14.
Singh said FDI equity inflows from EU to India from April 2012 to May 2015 was USD 24,913 million. In 2014-15, the amount was USD 8,207 million while in 2013-14, it was 9,069 million.
Meannwhile, Government has deferred talks with the European Union on the proposed free trade agreement, peeved at the ban imposed on around 700 pharma products which were clinically tested by GVK Biosciences.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 06 2015 | 5:32 PM IST

Next Story